Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/52553| Title: | Editorial: Inflammation and not glucocorticoid therapy is the key driver of fracture risk in IBD. | Authors: | Holt D.;Ebeling P. | Monash Health Department(s): | Nutrition and Dietetics Allied Health Gastroenterology and Hepatology Monash University - School of Clinical Sciences at Monash Health Endocrinology |
Institution: | (Holt, Ebeling) Clinical Nutrition and Metabolism Unit, Monash Health, Melbourne, VIC, Australia (Holt) Department of Gastroenterology and Hepatology, Monash Health, Melbourne, VIC, Australia (Holt, Ebeling) Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia (Ebeling) Department of Endocrinology, Monash Health, Melbourne, VIC, Australia |
Issue Date: | 9-Oct-2024 | Copyright year: | 2024 | Publisher: | John Wiley and Sons Inc | Place of publication: | United Kingdom | Publication information: | Alimentary Pharmacology and Therapeutics. (no pagination), 2024. Date of Publication: 2024. | Journal: | Alimentary Pharmacology and Therapeutics | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1111/apt.18311 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/52553 | Type: | Editorial | Subjects: | fracture inflammation inflammatory bowel disease glucocorticoid |
Type of Clinical Study or Trial: | Opinion, perspective or news |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.